She notes that Japan last year started classifying oncology as an independent discipline to be licensed, and in Korea there are already nationally licensed oncology specialists. But in Taiwan, oncology specialist licensing is carried out by the Chinese Oncology Society, lacking the public trust and status given by national accreditation.
她指出，日本在去年開始將腫瘤獨立為一個科別，韓國也已經有了腫瘤專科，但台灣的腫瘤專科醫師認證仍停留在癌症醫學會自行認證階段，缺乏國家賦予的公信力與地位。